Skip to content

Clinical trials

Phase 3 Rectal Neoplasms trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rectal Neoplasms Phase: Phase 3 Country / region: Netherlands Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20031
20041
20101
20111
20121
20131
20152
20162
20202
20211
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Unknown status6
Active, not recruiting3
Recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC3
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)2
Amsterdam UMC, location VUmc2
Amgen1
Catharina Ziekenhuis Eindhoven1
Dutch Colorectal Cancer Group1
Erasmus Medical Center1
LifeBond Ltd.1
Merck Sharp & Dohme LLC1
Mirati Therapeutics Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rectal Neoplasms19
Colonic Neoplasms8
Colorectal Neoplasms8
Neoplasm Metastasis2
Anastomotic Leak1
Breast Neoplasms1
Colonic Diseases1
Digestive System Diseases1
Digestive System Neoplasms1
Gastrointestinal Diseases1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.